X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (756) 756
Publication (34) 34
Newsletter (15) 15
Book Review (4) 4
Paper (2) 2
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gliclazide (491) 491
pharmacology & pharmacy (281) 281
gliclazide - pharmacology (275) 275
humans (266) 266
male (243) 243
animals (237) 237
hypoglycemic agents - pharmacology (167) 167
index medicus (166) 166
rats (161) 161
diabetes mellitus, type 2 - drug therapy (114) 114
female (114) 114
diabetes (100) 100
middle aged (99) 99
endocrinology & metabolism (97) 97
gliclazide - therapeutic use (95) 95
sulfonylurea compounds - pharmacology (95) 95
blood glucose - metabolism (86) 86
adult (78) 78
hypoglycemic agents - therapeutic use (77) 77
glibenclamide (76) 76
insulin (75) 75
aged (70) 70
pharmacokinetics (69) 69
solubility (69) 69
glyburide - pharmacology (67) 67
hypoglycemic agents - administration & dosage (67) 67
type 2 diabetes (67) 67
gliclazide - administration & dosage (66) 66
gliclazide - chemistry (65) 65
insulin - metabolism (63) 63
gliclazide - pharmacokinetics (62) 62
glucose (60) 60
diabetes mellitus (57) 57
hypoglycemic agents - chemistry (57) 57
rats, wistar (57) 57
insulin secretion (56) 56
diabetes mellitus, experimental - drug therapy (55) 55
oxidative stress (55) 55
diabetes mellitus, type 2 - blood (54) 54
hypoglycemic agents - pharmacokinetics (54) 54
metformin (52) 52
hypoglycemic agents (50) 50
in vitro techniques (50) 50
mellitus (50) 50
sulfonylurea (50) 50
administration, oral (48) 48
pharmacology/toxicology (47) 47
blood glucose - drug effects (46) 46
dose-response relationship, drug (44) 44
insulin - blood (44) 44
kinetics (44) 44
gliclazide - blood (41) 41
sulfonylureas (41) 41
time factors (41) 41
islets of langerhans - drug effects (39) 39
islets of langerhans - metabolism (37) 37
analysis (36) 36
chemistry, medicinal (35) 35
diabetes mellitus, experimental - metabolism (34) 34
glimepiride (34) 34
biochemistry & molecular biology (33) 33
diabetes mellitus, experimental - blood (33) 33
hypoglycemia (33) 33
pharmacy (33) 33
sulfonylurea compounds - therapeutic use (33) 33
drug interactions (32) 32
drugs (32) 32
in-vitro (32) 32
pharmacology (32) 32
research (32) 32
biomedicine (31) 31
cells, cultured (31) 31
diabetes mellitus, type 2 - metabolism (31) 31
hypoglycemic agents - adverse effects (31) 31
medicine & public health (30) 30
tablets (30) 30
dissolution (29) 29
mice (29) 29
bioavailability (28) 28
calcium - metabolism (28) 28
glucose - pharmacology (28) 28
insulin - pharmacology (28) 28
internal medicine (28) 28
metabolism (28) 28
efficacy (27) 27
hypoglycemic agents - blood (26) 26
type 2 diabetes mellitus (26) 26
drug therapy (25) 25
drug therapy, combination (25) 25
glucose - metabolism (25) 25
hydrogen-ion concentration (25) 25
particle size (25) 25
therapy (25) 25
antioxidants (24) 24
blood glucose - analysis (24) 24
care and treatment (24) 24
rats, sprague-dawley (24) 24
tolbutamide (24) 24
chemistry, pharmaceutical (23) 23
diabetes mellitus - drug therapy (23) 23
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (740) 740
Japanese (9) 9
French (8) 8
Russian (5) 5
Chinese (4) 4
Italian (3) 3
Spanish (3) 3
Croatian (2) 2
Hungarian (2) 2
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1985, ISBN 0306418436, xv, 473
Book
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 12/2016, Volume 389, Issue 12, pp. 1315 - 1324
Since chronic kidney disease due to diabetic nephropathy (DN) is becoming an ever larger health burden worldwide, more effective therapies are desperately... 
Oxidative stress | Neurosciences | Biomedicine | Gliclazide | Aliskiren | Diabetic nephropathy | Pharmacology/Toxicology | Renin-angiotensin system | COMBINATION | BLOOD-PRESSURE | INSULIN-RESISTANCE | PHARMACOLOGY & PHARMACY | RENIN INHIBITOR | EXPRESSION | ANGIOTENSIN-II BLOCKADE | PROGRESSION | PEROXIDE | Urological Agents - pharmacology | Diabetes Mellitus, Experimental - drug therapy | Kidney - pathology | Rats, Wistar | Apoptosis - drug effects | Streptozocin | Diabetic Nephropathies - blood | Insulin - blood | Diabetes Mellitus, Experimental - blood | Heart Rate - drug effects | Insulin-Secreting Cells - metabolism | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Diabetes Mellitus, Type 1 - chemically induced | Inflammation Mediators - metabolism | Female | Blood Pressure - drug effects | Diabetes Mellitus, Experimental - chemically induced | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Experimental - physiopathology | Amides - pharmacology | Kidney - drug effects | Anti-Inflammatory Agents - pharmacology | Diabetes Mellitus, Type 1 - physiopathology | Diabetic Nephropathies - chemically induced | Antioxidants - pharmacology | Biomarkers - blood | Apoptosis Regulatory Proteins - metabolism | Diabetes Mellitus, Type 1 - drug therapy | Hypoglycemic Agents - pharmacology | Blood Glucose - drug effects | Animals | Insulin-Secreting Cells - drug effects | Diabetes Mellitus, Type 1 - blood | Fumarates - pharmacology | Gliclazide - pharmacology | Oxidative Stress - drug effects | Blood Glucose - metabolism | Hypertension | Antioxidants | Heart beat | Chronic kidney failure | Nitric oxide | Diabetic nephropathies | Angiotensin | Bone morphogenetic proteins | Superoxide | Transforming growth factors
Journal Article
Journal of Microencapsulation, ISSN 0265-2048, 3/2015, Volume 32, Issue 2, pp. 151 - 156
Journal Article
International Journal of Biological Macromolecules, ISSN 0141-8130, 06/2013, Volume 57, pp. 129 - 137
Aceclofenac-loaded alginate/gellan gum microspheres for prolonged aceclofenac release were prepared through maleic anhydride-induced unsaturated... 
Drug release | Microspheres | Alginate | Drug delivery | Oral drug delivery | FTIR | POLYMER SCIENCE | ACID | BIOCHEMISTRY & MOLECULAR BIOLOGY | SIZE | PARAMETERS | GELATION | RELEASE | FORMULATION | BEADS | GLICLAZIDE | OPTIMIZATION | ORAL DELIVERY | CHEMISTRY, APPLIED | Inflammation - chemically induced | Diclofenac - pharmacology | Biocompatible Materials - chemistry | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Delayed-Action Preparations - chemistry | Male | Hexuronic Acids - pharmacokinetics | Diclofenac - chemistry | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Inflammation - drug therapy | Delayed-Action Preparations - pharmacology | Delayed-Action Preparations - pharmacokinetics | Glucuronic Acid - chemistry | Alginates - pharmacokinetics | Carrageenan - toxicity | Disease Models, Animal | Alginates - pharmacology | Polysaccharides, Bacterial - chemistry | Polysaccharides, Bacterial - pharmacology | Rabbits | Diclofenac - analogs & derivatives | Administration, Oral | Rats | Biocompatible Materials - pharmacology | Glucuronic Acid - pharmacokinetics | Hexuronic Acids - chemistry | Rats, Sprague-Dawley | Diclofenac - pharmacokinetics | Glucuronic Acid - pharmacology | Animals | Alginates - chemistry | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Biocompatible Materials - pharmacokinetics | Polysaccharides, Bacterial - pharmacokinetics | Hexuronic Acids - pharmacology | Analysis | Carrageenin | Maleic anhydride
Journal Article
Behavioural Pharmacology, ISSN 0955-8810, 04/2012, Volume 23, Issue 2, pp. 153 - 161
Diabetic neuropathy is the most common chronic complication of diabetes. The aim of the present study was to evaluate the protective effects of curcumin... 
pain | rat | gabapentin | neuropathy | diabetes | curcumin | gliclazide | KAPPA-B ACTIVATION | OXIDATIVE STRESS | LIPID-PEROXIDATION | PHOTO-IRRADIATED CURCUMIN | NITRIC-OXIDE SYNTHASE | DOWN-REGULATION | NEUROSCIENCES | TUMOR-NECROSIS-FACTOR | RADICAL SCAVENGER | BEHAVIORAL SCIENCES | PHARMACOLOGY & PHARMACY | C-PEPTIDE | NITROGEN-DIOXIDE | Analgesics - pharmacology | Diabetic Neuropathies - blood | Diabetes Mellitus, Experimental - drug therapy | C-Peptide - blood | Tumor Necrosis Factor-alpha - blood | Male | gamma-Aminobutyric Acid - administration & dosage | Gliclazide - administration & dosage | Curcumin - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Diabetes Mellitus, Experimental - blood | Peroxynitrous Acid - blood | Gliclazide - therapeutic use | Hypoglycemic Agents - administration & dosage | Lipid Peroxides - blood | Amines - therapeutic use | Amines - administration & dosage | Pain Threshold - drug effects | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Experimental - complications | gamma-Aminobutyric Acid - therapeutic use | Hypoglycemic Agents - therapeutic use | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Curcumin - therapeutic use | Diabetic Neuropathies - prevention & control | Curcumin - pharmacology | Analgesics - administration & dosage | Cyclohexanecarboxylic Acids - administration & dosage | Rats | gamma-Aminobutyric Acid - pharmacology | Rats, Sprague-Dawley | Hypoglycemic Agents - pharmacology | Blood Glucose - drug effects | Drug Therapy, Combination - methods | Animals | Hyperalgesia - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Cyclohexanecarboxylic Acids - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Gliclazide - pharmacology | Amines - pharmacology | Pain perception | Peroxynitrite | Streptozocin | Diabetes mellitus | Lipid peroxidation | Data processing | Glucose | Neuropathy | Serum levels | peroxide | Curcumin | Tumor necrosis factor- alpha | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2018, Volume 13, Issue 5, p. e0197634
Journal Article
Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 01/2000, Volume 43, Issue 1, pp. 83 - 90
Aims/hypothesis. It has been recently shown that glycated human haemoglobin induces endothelial dysfunction in rat vessels by generating superoxide anions that... 
Glycated haemoglobin, endothelial dysfunction, nitric oxide, superoxide anions, antioxidants, human microvessels | Antioxidants | Human microvessels | Endothelial dysfunction | Glycated haemoglobin | Superoxide anions | Nitric oxide | nitric oxide | OXIDATIVE STRESS | antioxidants | human microvessels | ENDOTHELIUM-DEPENDENT RELAXATION | REACTIVITY | MELLITUS | endothelial dysfunction | FREE-RADICALS | GLYCOSYLATED HUMAN HEMOGLOBIN | GLICLAZIDE | ARTERIES | ENDOCRINOLOGY & METABOLISM | superoxide anions | DYSFUNCTION | glycated haemoglobin | INDUCED DIABETIC RATS | Catalase - pharmacology | Free Radical Scavengers - pharmacology | Humans | Glycated Hemoglobin A - pharmacology | Thiourea - pharmacology | Microcirculation - drug effects | Microcirculation - physiology | Potassium Chloride - pharmacology | Omentum - blood supply | Vasodilation - physiology | Bradykinin - pharmacology | NG-Nitroarginine Methyl Ester - pharmacology | Splanchnic Circulation - drug effects | Superoxide Dismutase - pharmacology | Rats | Nitric Oxide - physiology | Indomethacin - pharmacology | Animals | Splanchnic Circulation - physiology | Ascorbic Acid - pharmacology | Gliclazide - pharmacology | Vasodilation - drug effects | Glycated Hemoglobin A - physiology | In Vitro Techniques | Thiourea - analogs & derivatives | Hypertension | COX-2 inhibitors | Vasodilators | Hemoglobin | Superoxide | Indomethacin | Glibenclamide | Organic acids
Journal Article